Why the study?
Do pre-procedural serum Angiopoietin-2 (Ang-2) levels predict periprocedural myocardial injury in patients undergoing elective PCI?
Do pre-procedural serum Angiopoietin-2 (Ang-2) levels predict periprocedural myocardial injury in patients undergoing elective PCI?
Pre-procedural Ang-2 levels do not predict periprocedural myocardial injury in elective PCI, but post-procedural Ang-2 dynamics are altered in patients who experience injury, and baseline NT-proBNP is an independent predictor.
Answers are grounded in this paper and cite their sources.
Baseline Ang-2 should not inform PMI risk stratification before elective PCI; leaves open NT-proBNP integration and post-procedural dynamics.
percentile upper reference limit. Blood samples for Ang-2 analysis were collected at admission and on postoperative days 1 and 3. PMI occurred in 40 patients (28%). At baseline, there was no difference in Ang-2 levels between PMI and non-PMI patients (P=0.554). However, a significant interaction effect between PMI occurrence and time on Ang-2 levels was observed (interaction P=0.036). Although serum Ang-2 levels in non-PMI patients gradually decreased, Ang-2 levels in PMI patients did not change between different time-points. Multiple logistic regression analysis revealed that age, total stent length, and serum levels of N-terminal pro-brain natriuretic peptide were independent PMI predictors. These findings indicate that pre-procedural Ang-2 levels do not impact PMI occurrence after elective PCI. However, changes in Ang-2 levels after the procedure are closely related to PMI.
No takes yet. Share an insight, caveat, or question.
Jian et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: